Based on such observations, serious precautions have to be taken, and it can be inferred that there is a likelihood that the CpG site cg16785077 (MX1) may lead to SSPE symptoms through the gene ATP6V1B2. This evidence concerns the gene ATP6V1B2 and subacute sclerosing panencephalitis.